Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties and therapeutic goals.
Injectable parenteral systems comprise solutions, dispersions, microspheres, and nanoparticles. Solutions often incorporate viscosity-modifying agents, form complexes, or exploit partitioning behavior to regulate drug release rates. Dispersed systems, such as emulsions and suspensions, control release through droplet or particle size, as well as the physical and chemical properties of the formulation. Oil-based dispersions further enable sustained drug action. Microspheres, composed of biodegradable polymers, are particularly well-suited for the controlled release of biologics, such as proteins and peptides, offering protection from enzymatic degradation and prolonging therapeutic action.
Implants are solid, surgically inserted devices designed for the long-term release of drugs. Their materials must show stability, biocompatibility, and, in some applications, removability. Implants are used in chronic conditions where consistent dosing is necessary over extended periods.
Infusion devices provide an alternative mechanism for controlled parenteral delivery. Osmotic pumps use semipermeable membranes to generate pressure differentials, allowing for a steady and controlled drug release rate. Vapor pressure systems rely on the expansion of volatile fluids to propel the drug, whereas battery-powered pumps use microprocessors to regulate precise dosing schedules. These systems are particularly effective in managing conditions requiring meticulous dose control.
Parenteral drug delivery systems maintain therapeutic drug concentrations over time, enhancing bioavailability, reducing the need for frequent dosing, minimizing systemic side effects, and improving patient compliance.
Parenteral DDS release drugs in a controlled manner through intravenous, intramuscular, or subcutaneous routes.
They include injectables, implants, and infusion devices.
Injectables include solutions and dispersions, microspheres, and nanoparticles.
Solutions control drug release via viscosity changes, complexation, or partitioning.
Dispersions, like emulsions and suspensions, use particle size and formulation to regulate drug release.
Microspheres use biodegradable polymer matrix to enable sustained delivery, especially for proteins and peptides.
Implants are surgically inserted devices for extended drug release and must be stable, biocompatible, and, sometimes, removable.
Infusion devices like osmotic pumps, vapor pressure systems, and battery-powered pumps deliver precise doses.
Osmotic pumps create pressure gradients using semipermeable membranes, vapor pressure systems rely on volatile fluids, and battery-powered pumps use electronics for timed delivery.
These systems enhance bioavailability, minimize side effects, and promote patient adherence through sustained release.
繁體中文
